At a glance
ClinicalIndex Comparison RecordN/ACompleted· 115 enrolled
Drug / intervention
Blood sampleother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Peripheral Markers of Inflammation in Patients With Alzheimer's Disease Compared to Cognitively Normal Elderly
In Brief
An observational study evaluating Blood sample for Alzheimer's Disease. Completed, enrolled 115 participants across 1 site.
Detailed Summary
The study aims to identify immune biomarkers in peripheral blood for identifying Alzheimer's disease (AD). Blood samples from subjects with AD will be compared to age-matched controls without cognitive symptoms, as well as healthy younger subjects.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAlzheimer's Disease
CountriesIsrael
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2007
First PostedJun 2015
Primary CompletionJun 2016
TodayJul 2026
First PostedJun 16, 2015
Enrollment StartFeb 1, 2007
Primary CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 9.3 yearsPosted 11.0 years ago
Interventions
Blood sampleother
Non-interventional study based on blood samples taken at a single study visit